Navigation Links
Cellular Dynamics Announces Presentations at the Society of Toxicology's 52nd Annual Meeting Demonstrating the Expanding Impact of iPSC-Derived Human Cells on Toxicology Assay Development
Date:3/8/2013

MADISON, Wis., March 8, 2013 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI), a leading commercial producer of human induced pluripotent stem cell (iPSC) lines and tissue cells for drug discovery, safety, stem cell banking and cellular therapeutics, today announced scientific presentations at the Society of Toxicology's 52nd Annual Meeting (SOT), March 10 to 14 in San Antonio, that demonstrate the expanding utility of CDI's iCell® products on toxicology assay development.

"Now that several iPSC-derived human cell types are reliably available in sufficient quantities and at high quality and purity, scientists from academia, government and industry are finding new ways to incorporate them into their toxicology assays," said Chris Parker , chief commercial officer of CDI.  "The scientific data presented at this conference are evidence of the increasing impact that the commercial availability of human cells is having on assay development for toxicity testing and validation of the cells' predictivity."

Researchers will present results on assays that use CDI's iCell Cardiomyocytes, iCell Neurons and iCell Hepatocytes in a variety of toxicology assays, including:

Chantest and ACEA Biosciences detail the use of the xCELLigence Cardio System to evaluate iCell Cardiomyocytes for sensitivity to compounds with broad mechanisms of action. (Exhibitor-hosted sessions, March 11, 9:15 - 10:15 a.m., and 1 - 2 p.m., Room 007B)

LeCluyse, E (The Hamner Institutes for Health Services) provides an overview on iPSC-derived hepatocytes, focusing on their utility in understanding hepatotoxicity mechanisms. (Exhibitor-hosted session, March 13, 1 - 2 p.m., Room 007 B)

Smith, G et al. (Abstract 85, poster 119
'/>"/>

SOURCE Cellular Dynamics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
2. Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
3. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
4. EastBridge Investment Group Announces Merger with Cellular Biomedicine Group
5. CeeTox and Cellular Dynamics Collaborate to Offer Predictive In Vitro Test for Cardiotoxicity Using Human iPSC-derived Cells
6. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
7. Cellular Dynamics Launches MyCell™ Services
8. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of AngioDynamics Inc. in Connection with Executive Compensation
9. Transonic Systems Selects Infinity Info Systems To Implement Microsoft Dynamics CRM To Drive Business Performance And Operational Excellence
10. Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
11. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... DIEGO , Nov. 24, 2014  GlySens Incorporated ... two million dollar grant from the National Institute of ... of the National Institutes of Health (NIH).  The grant ... GlySens second generation ICGM™ long term implantable glucose monitoring ... underway, and enrollment is expected to begin before the ...
(Date:11/24/2014)... Pa. , Nov. 24, 2014  Inovio Pharmaceuticals, Inc. ... J. Joseph Kim , President and CEO of Inovio Pharmaceuticals, ... management team to ring the Nasdaq Opening Bell tomorrow, Tuesday ... Inovio,s September 15 th listing on the Nasdaq Global ... ceremony, Dr. Kim said, "We are honored to ring the ...
(Date:11/22/2014)... 2014  New data demonstrates that flibanserin, a novel, ... of female sexual dysfunction, Hypoactive Sexual Desire Disorder (HSDD), ... in premenopausal women when taken at bedtime. The data ... North America,s (SMSNA) 20th Annual Fall ... SMSNA accepted this study as a late ...
Breaking Medicine Technology:GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3
... The National,Comprehensive Cancer Network (NCCN) announces updates to ... Cancer,and Gastric Cancer. The NCCN Guidelines are updated ... recognized and,applied as the standard of care in ... and the academic practice settings., In response to ...
... of the Most Challenging Patient Populations,Studied of Any ... PARK, Calif., May 22, 2007,/PRNewswire-FirstCall/ -- XTENT, Inc. ... clinical trial, which assessed,the safety and efficacy of ... for the treatment of long and,multiple lesions in ...
Cached Medicine Technology:NCCN Updates Esophageal and Gastric Cancer Guidelines 2NCCN Updates Esophageal and Gastric Cancer Guidelines 3XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 2XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 3XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 4
(Date:11/24/2014)... 24, 2014 Gersowitz Libo & Korek, P.C., ... received national Tier recognition in the 2015 Edition of U.S. ... ranking signals a unique combination of quality law practice and ... receive this honor and especially grateful to our clients whose ... and ranking possible,” said Jeff S. Korek, senior partner at ...
(Date:11/23/2014)... iFitDress.com, a well-known wedding dress manufacturer, has unveiled ... They are now offered at deeply discounted prices, up ... now to Dec. 15. The main purpose of the promotion ... high quality items are ideal options for ladies who are ... money. All its new mint cocktail dresses are very beautiful; ...
(Date:11/23/2014)... November 23, 2014 Pro Ace Care, a ... it will now be providing an 8 year warranty on ... water tank installations went up due to the impending winter ... its customers of the premium service that the company provides. ... year warranty on John Wood and Bradford hot water tanks. ...
(Date:11/23/2014)... 2014 Locks-Magnetic.com, a notable magnetic locks ... all the new products are available at low rates ... is proud of the new emergency doors. The emergency ... customers can choose from several colors. All of the ... emergency door release is not as easy as many ...
(Date:11/23/2014)... More than two dozen new claims ... litigation involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), as well ... reports. , A Case List updated on November ... Type 2 diabetes medications referred to as incretin mimetics ... Southern District of California, where a federal proceeding continues ...
Breaking Medicine News(10 mins):Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4
... after women have separated from an abusive partner, the violence still ... at the University of British Columbia. Led by UBC Nursing ... of Canadian Public Policy is the first in ... used by women who leave a violent partner. Overall, ...
... and Reinvestment Act award from the Agency for Healthcare ... Indiana Network for Patient Care (INPC), the nation,s largest ... simultaneously supports a groundbreaking comparative effectiveness research study using ... harms of three drugs commonly used to treat Alzheimer,s ...
... A pioneering international collaboration forged by Fred Hutchinson ... with the Uganda Cancer Institute in Kampala, Uganda, ... a state-of-the-art cancer training and outpatient treatment facility ... comprehensive cancer center jointly constructed by U.S. and ...
... by University of Cincinnati (UC) faculty members shows that ... clinical experience helps internal medicine residents improve their scores ... findings, published in the advance online edition of the ... print in November, validate the benefit of this and ...
... of 606 Canadian physicians were disciplined by their provincial ... St. Michael,s Hospital found. The majority of disciplined ... practicing medicine for a long time (an average of ... according to Dr. Chaim Bell. The most frequent ...
... wild, poisonous mushroom growing in a Southwest China forest appears ... report. , The compound, verticillin A, sensitizes cancer cells to ... said Dr. Kebin Liu, cancer immunologist at the Georgia Health ... in the journal Cancer Research . , The compound ...
Cached Medicine News:Health News:Annual cost of violence pegged at $6.9 billion after women leave abusive partners, UBC research 2Health News:$8.4 million grant supports health information exchange and research on Alzheimer's drugs 2Health News:Hutchinson Center breaks ground for first collaborative cancer center in sub-Saharan Africa 2Health News:Hutchinson Center breaks ground for first collaborative cancer center in sub-Saharan Africa 3Health News:Hutchinson Center breaks ground for first collaborative cancer center in sub-Saharan Africa 4Health News:Hutchinson Center breaks ground for first collaborative cancer center in sub-Saharan Africa 5Health News:New testing program improves scores, knowledge retention for third-year internal medicine residents 2Health News:New testing program improves scores, knowledge retention for third-year internal medicine residents 3Health News:Researchers track number of doctors disciplined and why 2Health News:Mushroom compound appears to improve effectiveness of cancer drugs 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: